Home Nitric Oxide Therapy for COVID-19
American Journal of Respiratory and Critical Care Medicine
; 202(1):16, 2020.
Artículo
en Inglés
| ProQuest Central | ID: covidwho-2098100
ABSTRACT
Alvarez et al discuss a case study on home nitric oxide therapy for COVID-19. Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes a range of cardiopulmonary and vascular complications, ranging from upper respiratory tract symptoms to severe acute respiratory distress syndrome (ARDS), as well as shock, acute kidney injury, and thromboembolic complications. Zamanian and colleagues present an interesting and compelling case of a patient with pulmonary arterial hypertension (PAH) who was treated remotely in an ambulatory setting with inhaled nitric oxide (iNO) (5). This patient with well-controlled vasoreactive PAH lived in a remote area more than 300 miles away from their center and experienced symptoms of worsening breathlessness after being diagnosed with COVID-19.
Texto completo:
Disponible
Colección:
Bases de datos de organismos internacionales
Base de datos:
ProQuest Central
Idioma:
Inglés
Revista:
American Journal of Respiratory and Critical Care Medicine
Año:
2020
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS